Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Yi Tat Tong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4621-5800; OpenAlex author ID A5071515798. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 3

  1. The Association between Sampling and Survival in Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy. Co-author DOI 10.3390/cancers16193312↗
  2. Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy. Co-author DOI 10.3390/cancers15092608↗
  3. GRP78 expression and prognostic significance in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy versus surgery first. Co-author DOI 10.1016/j.pan.2021.08.006↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Matthew H. G. Katz · 3 shared papers, 2021–2024 · strength 0.44
  2. Robert A. Wolff · 3 shared papers, 2021–2024 · strength 0.44
  3. Laura R. Prakash · 3 shared papers, 2021–2024 · strength 0.44
  4. Michael P. Kim · 3 shared papers, 2021–2024 · strength 0.44
  5. Anirban Maitra · 3 shared papers, 2021–2024 · strength 0.44
  6. Eugene Jon Koay · 3 shared papers, 2021–2024 · strength 0.44
  7. Ching-Wei David Tzeng · 3 shared papers, 2021–2024 · strength 0.44
  8. Dan Zhao · 2 shared papers, 2023–2024 · strength 0.33
  9. Hua Wang · 2 shared papers, 2023–2024 · strength 0.33
  10. Deyali Chatterjee · 2 shared papers, 2023–2024 · strength 0.33
  11. Naruhiko Ikoma · 2 shared papers, 2023–2024 · strength 0.33
  12. Huamin Wang · 2 shared papers, 2021–2024 · strength 0.29
  13. Jeffrey E. Lee · 2 shared papers, 2021–2023 · strength 0.27
  14. Mehran Taherian · 1 shared paper, 2024 · strength 0.18
  15. Huamin Wang · 1 shared paper, 2023 · strength 0.15
  16. Dongguang Wei · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.